2026. Co-Therapy of Silymarin and Vitamin E Attenuates Doxorubicin-Induced Hepatotoxicity in Rats by Mitigating Oxidative Damage and Preserving Hepatic Architecture. Tikrit Journal of Pharmaceutical Sciences. 20, 1 (Jun. 2026), 20–32. DOI:https://doi.org/10.25130/tjphs.2026.20.1.3.20.32.